Zentalis Pharmaceuticals, Inc.

SEC 4 · Filed

0001628280-26-064317Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Sep 30, 2026

Grant, award or other acquisition by Bruns Ingmar

Security
Common Stock
Code
A
Shares
9,727
Price per share
2.18
Structured facts
{
  "code": "A",
  "date": "2026-09-30",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "The reporting person is voluntarily reporting the acquisition of shares of the Issuer\u0027s common stock pursuant to the Issuer\u0027s 2020 Employee Stock Purchase Plan (\"ESPP\") for the ESPP purchase period of April 1, 2026 through September 30, 2026. This transaction is exempt under Rule 16b-3(c).",
    "F2": "In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer\u0027s common stock on April 1, 2026."
  },
  "owners": [
    {
      "cik": "0001838041",
      "name": "Bruns Ingmar",
      "roles": [
        "officer"
      ],
      "title": "Chief Medical Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "43059",
  "price": "2.18",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Common Stock",
  "shares": "9727",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}